Reimagining Care and Research for ALS
This Viewpoint advocates for the expansion of clinical research in amyotrophic lateral sclerosis through the development of a well-organized network of centers and community-based clinics.
Related Articles
Episode 2: NIH funding, Rita Levi-Montalcini, and school-based resources for epilepsy | Podcast Episode on RSS.com
Ali and Sam check in with with Audrey Brumback and Divakar Mithal to break down the current NIH funding situation. Chaos ensues.
Frontiers | The potential anti-seizure effects of Astaxanthin-loaded nanostructured lipid carriers in rat model of status epilepticus
IntroductionEpilepsy is a common neurological disorder; seizures and hyperexcitability are its defining features in the central nervous system (CNS). The con…
Frontiers | PTEN in somatostatin neurons regulates fear and anxiety and is required for inhibitory synaptic connectivity within central amygdala
IntroductionThe phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is a negative regulator of the mTOR pathway and is strongly associated with au…
Headache: The Journal of Head and Face Pain | AHS Journal | Wiley Online Library
This study surveyed more than 6000 individuals with migraine in the United States using the Migraine Buddy smartphone app to better understand their diagnosis and…
Frontiers | Research progress on the neural circuits mechanisms of anxiety
Anxiety disorders, as a critical mental health issue, profoundly impact an individual’s quality of life and social participation while imposing a considerabl…
Trends in US Children’s Mortality, Chronic Conditions, Obesity, Functional Status, and Symptoms
This study aims to determine how US children’s health has been changing from 2007 to 2023 using multiple data collection methods and a comprehensive set…
Headache: The Journal of Head and Face Pain | AHS Journal | Wiley Online Library
To more fully understand the impact of migraine on individuals’ access to health care, we compared health care barriers faced by people with migraine to…
I Am Taking a GLP-1 Weight-Loss Medication—What Should I Know?
This JAMA Internal Medicine Patient Page describes how glucagon-like peptide-1 (GLP-1) receptor agonists work and what behaviors to adopt while using them.
Frontiers | Whole-genome sequencing shows modulation of neurodegenerative genes by Withania somnifera in human SK-N-SH cells
BackgroundAging is driven by several primary and secondary hallmarks that manifest with age, of which neurodegenerative diseases are important manifestations…
Anatomic Staging of H3 G34-Mutant Diffuse Hemispheric Glioma | Neurology
ObjectivesH3 G34-mutant diffuse hemispheric gliomas are rare, aggressive primary brain tumors predominantly affecting young patients. We investigated the prognostic value of anatomic staging (AS)—a system…
